An anti-human ICAM-1 antibody inhibits rhinovirus-induced exacerbations of lung inflammation.
Human rhinoviruses (HRV) cause the majority of common colds and acute exacerbations of asthma and chronic obstructive pulmonary disease (COPD). Effective therapies are urgently needed, but no licensed treatments or vaccines currently exist. Of the 100 identified serotypes, ∼90% bind domain 1 of huma...
Main Authors: | Stephanie Traub, Alexandra Nikonova, Alan Carruthers, Rebecca Dunmore, Katherine A Vousden, Leila Gogsadze, Weidong Hao, Qing Zhu, Katie Bernard, Jie Zhu, Michael Dymond, Gary R McLean, Ross P Walton, Nicholas Glanville, Alison Humbles, Musa Khaitov, Ted Wells, Roland Kolbeck, Andrew J Leishman, Matthew A Sleeman, Nathan W Bartlett, Sebastian L Johnston |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS Pathogens |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23935498/pdf/?tool=EBI |
Similar Items
-
An anti-human ICAM-1 antibody inhibits rhinovirus-induced exacerbations of lung inflammation
by: Traub, Stephanie, et al.
Published: (2013) -
Monocytes, B-cells and dendritic cells during rhinovirus-induced asthma exacerbation
by: R. M. Khaitov, et al.
Published: (2019-05-01) -
Rhinovirus infections and immunisation induce cross-serotype reactive antibodies to VP1
by: McLean, Gary R., et al.
Published: (2012) -
The potential for a protective vaccine for rhinovirus infections
by: Williams, Gareth R., et al.
Published: (2016) -
Epitope mapping of antibodies induced with a conserved rhinovirus protein generating protective anti-rhinovirus immunity
by: Narean, Janakan Sam, et al.
Published: (2019)